The pleiotropic cytokine interleukin-6 (IL-6) has been proposed to contribute to circadian regulation of sleepiness by increasing in the blood at night to signal for sleepiness. Earlier studies have reported diurnal variations of IL-6, but phase estimates are conflicting. We have therefore performed a meta-analysis on the diurnal variation of circulating IL-6. Studies were included if they reported circulating levels of IL-6 recorded at least twice within 24 hours in the same individual. A systematic search resulted in the inclusion of 43 studies with 56 datasets, for a total of 1100 participants. Individual participant data were available from 4 datasets with a total of 56 participants. Mixed-effects meta-regression modelling confirmed that IL-6 varied across the day, the most conspicuous effect being a trough in the morning. These results stand in contrast to earlier findings of a peak in the evening or night, and suggest that diurnal variation should be taken into account in order to avoid confounding in studies of IL-6 in plasma or serum.
about 10-30 pg/ml over the course of two days [73] . This is about ten times higher than 48 expected for healthy participants, raising questions about the validity of the absolute (see table 1 ). assumed to represent standard errors unless otherwise indicated. Time of day was coded, 61 as well as sleep or wake, time asleep, and time awake. For studies reporting participants 62 kept in the lab overnight, data obtained at the time-point when the lights-out period 63 began were coded as awake and data from the time-point when the lights-out period 64 ended were coded as asleep. When times for falling asleep and waking up were not 65 recorded or not reported, we assumed that they were 23:00 and 07:00. When applicable, 66 time from catheter insertion was also coded. Unless otherwise specified, serial sampling 67 with more than two samples within the same 24-hour period was assumed to have been 68 performed using an indwelling catheter inserted at the first sampling time point. Data 69 recorded during sleep deprivation were not included. IL-6 data were ln-transformed to 70 better approximate a normal distribution. For datasets where individual participant 71 data were not available, transformation was performed as described in [12] . 72 Individual participant data were available from 4 datasets, which were coded 73 separately (see table 1 ). In these datasets, data points below assay detection limits 74 (meaning lowest known point of assay linear range) were conservatively re-coded to the 75 value of the detection limit. In Sothern 1995 [13] , 7 values out of 88 (8%), ranging from 76 0.5 to 0.96 pg/ml, were re-coded to 1 pg/ml. In Karshikoff 2015 [14] , 23 values out of 83 77 (28%), ranging from 0.01 to 0.88 pg/ml, were re-coded to 0.9 pg/ml. 78 Ethical approval was not required. The study protocol was not registered. All data 79 and the full analysis code are freely available at 80 https://github.com/GNilsonne/IL6_diurnal. 81 Meta-analysis 82 To investigate the diurnal time course of IL-6 in plasma and possible moderator 83 variables, we used hierarchical mixed-effects models. This approach allows for more 84 complex model fitting and is expected to have higher statistical power compared to 85 fitting models separately in each dataset and then analysing summary measures such as 86 acrophase and amplitude. Diurnal variation was investigated by fitting cosinor functions 87 with periods of 24, 12, and 6 hours. Time from catheterisation was included with a 88 random slope for each data set in order to account for the proposed effect that 89 catheterization induces higher values in blood drawn from the catheter [15, 16] . Effects 90 of sleep were investigated exploratively with a binary factor for sleep/wake, as well as 91 time asleep and time awake. Datasets were weighted by the number of participants 92 multiplied by the square root of the number of time-points in each study. Models were 93 compared using likelihood ratio tests. Analyses were performed using R version 94 3.2.0 [17] with the nlme package [18] .
95

Results
96
Diurnal variation of IL-6 97 First, we fitted a null model including only time from catheterization and a random 98 intercept for each dataset. Fig 3 shows residuals after these effects have been accounted 99 for, suggesting that there remains variation to explain. The distribution of these 100 residuals suggests a morning trough in IL-6 levels (Fig 3) . Next, we compared a model 101 with a 24 h cosinor function to the null model. The 24 h cosinor model fit better (log 102 likelihood -483.5 vs -528.8, p < 0.0001, Fig 4) . We then added another cosinor function 103 with 12 h period. We did this for two reasons. The first reason was that addition of Individual participant data. Individual participant data were available from four datasets and are shown here mainly for the purpose of illustrating the high degree of variability within individuals. To illustrate summary effects within each dataset, thick lines show loess functions fitted to each dataset. Time from 22:00 to 07:00 is shaded to indicate the night. For Lekander 2013, two sets of measurements, made with a few days' interval, have been plotted over the same time course, in red and blue respectively. most of which were published in the 1990:s, were unable to find reliable data because 138 most values were close to or below assay detections limits ( Table 2 ). From the point of 139 view of bias, this is not a major problem since assay detection limits were unrelated to 140 time of day for sampling. More concerning are data that were not reported because no 141 effect was found. Only one paper explicitly stated that data were not shown for this 142 reason [66] . Additionally, an unknown number of studies with eligible data have never 143 been published. It is likely that unreported studies were more likely not to have found 144 significant effects. However, with regard to estimating diurnal phase, we suspect that 145 earlier investigators have been happy to report effects regardless of the location of peaks 146 and troughs, reflected in the wide variety of published estimates (Fig 1) . Therefore, 147 even though the first reports of diurnal effects reported peaks in the night, we suspect 148 that the studies included here were not strongly biased towards reporting effects at any 149 particular time of day. Furthermore, to the extent that earlier reports may have been 150 influenced by a prevailing theory, the effect most often referred to is a night-time peak. 151 Since our meta-analysis did not find a night-time peak, we think it is unlikely that a bias 152 in favor of this particular effect will have had a major influence on our model estimates. 153 Included datasets comprise both data from studies that were designed to measure 154 diurnal or circadian variation, and data from studies that incidentally happened to fulfil 155 our inclusion criteria. The latter group generally had fewer time points for 156 measurements. Since this meta-analysis uses mixed-effects meta-regression by time of scope of this paper, and as the sleep variable was not included in the best-fitting model, 170 the assumption only indirectly affects the risk of bias in diurnal variation. Since the 171 sleep variable made very little difference when added to the best-fitting model, it is 172 unlikely that a different assumption would lead to a different result.
173
Based on the above considerations, we judge that the risk of bias due to selective 174 publishing and data inclusion is probably moderate to low. For this reason, we are reluctant to consider the best-fitting model as proof 182 that there are two distinct peaks and/or troughs during the 24 h day.
183
Our analytical approach treats sleep as a confounder to be eliminated, in order to 184 best estimate diurnal variation. The effect of sleep on circulating IL-6 is an interesting 185 question in its own right, but is better addressed by experimental sleep deprivation 186 studies, which were not investigated here. A recent meta-analysis of the effect of sleep 187 deprivation on IL-6 included 12 studies and found no significant effect [20] .
188
One previous meta-analysis [9] (reported again in [10] and [11] ) has investigated 189 diurnal variation of circulating IL-6. As discussed in the introduction, this earlier 190 meta-analysis aimed primarily to describe diurnal variation in patients with rheumatoid 191 arthritis, and no systematic method to find data from healthy participants was 192 described. Compared to this earlier meta-analysis, we have used a more systematic 193 approach and we include more data (k = 56 datasets compared to k = 11). The present 194 findings contrast markedly with those of the earlier meta-analysis, as that study located 195 a morning peak at approx. 06:00 in healthy controls (Fig 1) as well as in patients with 196 rheumatoid arthritis, while we report a morning trough at about 08:00-09:00 in healthy 197 humans. This raises the hypothesis that diurnal variation is different between healthy 198 humans and patients with rheumatoid arthritis, possibly correlating in patients to the 199 diurnal time course of symptoms such as joint stiffness and pain, which tend to be worse 200 in the morning.
201
The shape of the diurnal curve estimated in this meta-analysis is not suggestive of a 202 mechanism where the immune system secretes more IL-6 into the blood at night in 203 order to promote sleepiness. While the present results do not disprove this putative 204 mechanism, the lack of a night-time peak, compared to the afternoon, suggests that 205 other regulatory mechanisms are dominant.
206
The estimated morning trough is rather close after the time of day when cortisol 207 levels peak, and also close to the diurnal trough of monocyte and lymphocyte 208 concentrations in peripheral blood [95] [96] [97] . The data investigated here cannot speak 209 directly to the relationship between diurnal variation of IL-6 to cortisol and white blood 210 cell concentrations, and further studies will be required to elucidate whether any direct 211 links exist.
212
The diurnal variation estimated here is large enough to pose a risk of confounding if 213 sampling is performed without regard to time of day, and we therefore recommend that 214 time of day should be taken in to consideration in studies recording IL-6 in plasma or 215 serum from healthy humans. Further research is required to determine conclusively 216 whether other cytokines also show diurnal variation. As far as we are aware, IL-6 is the 217 the only cytokine to date to be subject to a meta-analysis of diurnal variation. 100 a: Individual participant data were available. b: Some data were given in time relative to sleep onset or wake-up, and were re-coded using mean chronological time as a best approximation. c: Averaged over 3 consecutive days. d: 358 of 385 participants were included in analyses of IL-6. Final n for each sub-group was not given, and was therefore conservatively coded as the lowest possible n in each sub-group. Error bars were denoted as standard deviation, but were coded as standard errors because they were incredibly small for standard deviations. e: Each dataset was said to have 50% of the total participants (n = 41), and both were conservatively coded as n = 20. f: 15 of 16 participants could be identified in the graph. g: The same 7 participants were included twice with a 10-week interval, yielding two different data sets. h: We have previously published data from this study [63] . 
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